{"nct_id":"NCT01730053","title":"Study of Alirocumab (REGN727/SAR236553) added-on to Rosuvastatin Versus Other Lipid Modifying Treatments (LMT) (ODYSSEY OPTIONS II)","status":"COMPLETED","status_verified_date":"2020-03","start_date":"2012-11-30","start_date_type":"ACTUAL","primary_completion_date":"2014-04-30","primary_completion_date_type":"ACTUAL","completion_date":"2014-05-31","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["REGN"]}